Arbutus Biopharma | Results Presentation Deck | 15 slides

Arbutus Biopharma · 2022-11
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

1
coverage by narrative range · generated from this deck JSON
Narrative range 15 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 15 slides 100% 15/15 slides 100% 15/15 slides · 55 hits
0/15 slides
46.7% 7/15 slides 13.3% 2/15 slides
0/15 slides
0/15 slides

Slide inventory

15
every slide · same image gating as the playbook
01
Slide 1
Includes company logo, ticker, website, and date.front_matter
03
Includes cohort definitions and a detailed baseline characteristics table for multiple cohorts.analyze_data
04
Data presented at AASLD 2022. Includes footnote regarding LLOQ and specific cohort exclusions.analyze_data
05
Data presented at AASLD 2022. Charts show individual patient trajectories over time (weeks) on a log scale.analyze_data
06
Each chart represents a different patient (Pt. 46-61). The legend applies to all charts: Red=HBsAg, Green=ALT, Blue=HBV DNA.analyze_data
07
The slide uses a bulleted list with circular icons to present key safety findings.summarize
08
The slide uses a vertical timeline-like structure to present five key product attributes.summarize
09
The slide outlines a clinical trial design with three arms and a follow-up period, followed by a summary of findings.summarize
10
The chart shows mean changes in HBsAg from baseline. The table below the chart shows patient counts (n) for each group at each time point.analyze_data
11
The slide uses a process-oriented diagram to show how three distinct mechanisms combine to lead to a clinical outcome.present_solution
12
The slide uses a timeline-based experimental design on the left and a dot plot showing PD-L1 expression levels on the right.analyze_data
13
Data presented at AASLD 2022. Ex vivo FluoroSpot Day 42.analyze_data
14
summarize
15
summarize